BillionToOne FY2025 revenue doubled to USD 305.11 million

Reuters03-12
BillionToOne FY2025 revenue doubled to USD 305.11 million

BillionToOne reported FY 2025 net income of USD 7.45 million, compared with a net loss in FY 2024. FY 2025 revenue more than doubled to USD 305.11 million, driven by a 51% increase in delivered and billable tests to about 610,000 and a 35% increase in overall average selling price (ASP). FY 2025 gross margin rose 15 percentage points to 68%, with the company attributing about 86% of the improvement to higher overall ASP and about 14% to lower overall cost per test. FY 2025 operating income was USD 16.02 million, compared with an operating loss in FY 2024. FY 2025 net cash provided by operating activities was USD 24.6 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Billiontoone Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002070849-26-000017), on March 11, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment